John Theurer Cancer Center/ Hackensack Meridian Health

Hackensack, New Jersey 07601

1 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Multiple Myeloma, Multiple Myeloma, Refractory

Studies at this site

• EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma — Recruiting now
• Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy — Recruiting now
• A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy — Running, not enrolling
• Fluoroquinolone Resistance Prevalence Study — Stopped early
• Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM) — Stopped early
• Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma. — Withdrawn before enrolling